See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2018_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 131,605,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 231,628,000 |
| 2 | PropertyPlantAndEquipmentNet | 20,403,000 |
| 3 | remainder_Assets | 28,502,000 |
| 4 | LiabilitiesCurrent | 39,228,000 |
| 5 | LiabilitiesNoncurrent | 69,946,000 |
| 6 | remainder_Liabilities | 128,208,000 |
| 7 | CostOfGoodsAndServicesSold | 165,742,813 |
| 8 | SellingGeneralAndAdministrativeExpense | 34,913,016 |
| 9 | ResearchAndDevelopmentExpense | 7,737,599 |
| 10 | remainder_Expenses | 64,457,053 |
| 11 | remainder_Revenues | 417,285,164 |
| 12 | remainder_NetIncome | -11,940,301 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 412,138,000 |
| 1 | Liabilities | 237,382,000 |
| 2 | Expenses | 272,850,481 |
| 3 | Revenues | 417,285,164 |
| 4 | StockholdersEquity | 174,756,000 |
| 5 | NetIncome | 132,494,382 |
| 6 | ComprehensiveNetIncome | 132,494,382 |
| 7 | BaseVar | 675,797,973 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.58 |
| 9 | EconomicCapitalRatio | 2.74 |
Edgar->Model Mapping
Feature Distribution
Change over Time
